This inventor holds 2 USPTO granted patents. Top assignee: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Herwig Koppensteiner: Innovator in Antiviral Immunotherapy
Introduction
Herwig Koppensteiner is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of antiviral immunotherapy, focusing on innovative methods for treating viral infections. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Herwig Koppensteiner holds a patent for "Antiviral immunotherapy by membrane receptor ligation." This invention relates to a cytotoxic agent designed for the prophylaxis and treatment of viral infections. The agent selectively binds to a membrane receptor of virus-infected T lymphocytes. The patent also includes a pharmaceutical composition containing this cytotoxic agent, methods for finding such agents, and the use of the membrane receptor for diagnosing viral infections. He has 1 patent to his name.
Career Highlights
Koppensteiner is affiliated with the Eberhard Karls Universität Tübingen, specifically within the Medical Faculty. His academic and research endeavors have positioned him as a key figure in the study of viral infections and immunotherapy. His innovative approach has garnered attention in the scientific community.
Collaborations
Herwig Koppensteiner has collaborated with notable colleagues, including Michael Schindler and Marius Codrea. These partnerships have enhanced his research and contributed to the development of effective antiviral therapies.
Conclusion
Herwig Koppensteiner's work in antiviral immunotherapy exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for new treatment options for viral infections, showcasing the importance of research and collaboration in advancing healthcare.